The Spearman rank-order correlation coefficient rho (ρ)
Variables Axial
length MH size BCVA preop
(LogMAR) BCVA in 1 month follow- up (LogMAR)
BCVA in 6 months follow-up (LogMAR)
Duration of the symptoms Axial
length
correlation coefficient, ρ 1,000 -,167 ,670* ,332 ,077 -,613
Sig. (2-tailed) ,668 ,048 ,382 ,844 ,079
N 9 9 9 9 9 9
MH size correlation coefficient, ρ -,167 1,000 -,009 ,630 ,410 ,143
Sig. (2-tailed) ,668 ,983 ,069 ,273 ,714
N 9 9 9 9 9 9
BCVA preop (LogMAR)
correlation coefficient, ρ ,670* -,009 1,000 ,442 ,317 -,818**
Sig. (2-tailed) ,048 ,983 ,234 ,406 ,007
N 9 9 9 9 9 9
BCVA in 1 month follow-up (LogMAR)
correlation coefficient, ρ ,332 ,630 ,442 1,000 ,821** -,326
Sig. (2-tailed) ,382 ,069 ,234 ,007 ,392
N 9 9 9 9 9 9
BCVA in 6 months follow-up (LogMAR)
correlation coefficient, ρ ,077 ,410 ,317 ,821** 1,000 -,448
Sig. (2-tailed) ,844 ,273 ,406 ,007 ,226
N 9 9 9 9 9 9
Duration of the symptoms
correlation coefficient, ρ -,613 ,143 -,818** -,326 -,448 1,000
Sig. (2-tailed) ,079 ,714 ,007 ,392 ,226